BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 392153)

  • 1. [Pharmacodynamics of rifampicin--bacteriological and pharmacological action of rifampicin].
    Toyohara M
    Kekkaku; 1979 Dec; 54(12):576-8. PubMed ID: 392153
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bactericidal effect of rifampicin].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1976 Sep; (9):74-80. PubMed ID: 827746
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental studies of the antimycobacterial activity of Rifampicine].
    Nitti V; Catena E; Ninni A; Di Filippo A
    Arch Tisiol Mal Appar Respir; 1966 Nov; 21(11):867-910. PubMed ID: 4969274
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimycobacterial activity of rifampicin.
    Lucchesi M; Mancini P
    Antibiot Chemother; 1970; 16():431-43. PubMed ID: 5002307
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of rifampicin on the nonspecific reactivity and natural resistence to tuberculosis in guinea pigs].
    Shiniberov VA
    Probl Tuberk; 1979 Jan; (1):50-4. PubMed ID: 419108
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
    Pallanza R; Arioli V; Furesz S; Bolzoni G
    Arzneimittelforschung; 1967 May; 17(5):529-34. PubMed ID: 5631580
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifampicin effect on tuberculin hypersensitivity and humoral antibody response in tuberculous guinea-pigs.
    Algeorge G; Rudescu D
    Z Immunitatsforsch Exp Klin Immunol; 1973 Feb; 144(5):459-66. PubMed ID: 4282942
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifampicin and immunosuppression.
    Nessi R; Pallanza R; Fowst G
    Arzneimittelforschung; 1974 May; 24(5):832-6. PubMed ID: 4408351
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental evaluation of the antimycobacterial activity of rifampicin].
    Ninni A; Scoles E; Iodice F; Razza I
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):315-28. PubMed ID: 4981410
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental investigations of bacteriological mechanisms in short course chemotherapy.
    Dickinson JM; Mitchison DA
    Bull Int Union Tuberc; 1976; 51(1):79-86. PubMed ID: 829484
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the bactericidal activity in vivo of Rifampicin alone or associated with isoniazid].
    Nitti V; Ninni A; Natali P
    Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):859-70. PubMed ID: 4975183
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rifampicin and isoniazid in the intermittent treatment of experimental tuberculosis in guinea-pigs].
    Daddi G; Lucchesi M; Mancini P
    Ann Ist Carlo Forlanini; 1969; 29(1):35-40. PubMed ID: 5405839
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activity of Rifampicin associated with other drugs on experimental tuberculosis in guinea pigs].
    Nitti V; Ninni A
    Arch Tisiol Mal Appar Respir; 1967 Oct; 22(10):871-95. PubMed ID: 5304754
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mode of action of rifampicin on Mycobacterium tuberculosis].
    Konno K; Oizumi K; Hayashi I; Oka S
    Kekkaku; 1972 Aug; 47(8):255-60. PubMed ID: 4634136
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by means of Rifamycin SV susceptibility].
    Tsukamura M; Tsukamura S
    Igaku To Seibutsugaku; 1966 Jun; 72(6):350-2. PubMed ID: 4959327
    [No Abstract]   [Full Text] [Related]  

  • 17. [Resistance of tubercle bacilli to rifampicin in experimental tuberculosis induced in laboratory animals].
    Janowiec M; Wierzejska H
    Gruzlica; 1973 Mar; 41(3):251-7. PubMed ID: 4633122
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifampicin-susceptibility and rifampicin-resistance in mycobacteria.
    Manten A; van Wijngaarden LJ; van Klingeren B
    Acta Tuberc Pneumol Belg; 1969; 60(3):329-34. PubMed ID: 4984415
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental study of 2d order tuberculostatic preparations in Mycobacterium bovis resistance to isoniazid or streptomycin (based on the data from a morphological study)].
    Golyshevskaia VI; El'shanskaia MP
    Farmakol Toksikol; 1975; 38(2):222-4. PubMed ID: 776650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antitubercular effect of aminazin].
    Libenson VS; Braude VI
    Biull Eksp Biol Med; 1967 Feb; 63(2):61-3. PubMed ID: 4915071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.